X4 PHARMACEUTICALS INC (XFOR)
US98420X1037 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -128.92M | -101.17M | -93.87M | -88.70M | -62.13M | |||
| Depreciation Amortization | 351.00K | 419.00K | 510.00K | 500.00K | 350.00K | |||
| Change In Working Capital | 1.81M | 344.00K | 5.74M | -1.50M | -4.06M | |||
| Interest Paid | N/A | 4.60M | 3.01M | 2.91M | 2.10M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 23.15M | 3.89M | 10.52M | 18.79M | 7.03M | |||
| OPERATING CASH FLOW | -103.60M | -96.51M | -77.10M | -70.91M | -58.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -109.00K | -60.00K | -100.00K | -620.00K | -1.36M | |||
| Other Investing Activity | N/A | -14.82M | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -20.20M | -14.88M | -100.00K | -620.00K | -1.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 21.74M | 20.44M | -800.00K | 0.00 | 12.39M | |||
| Stock Issued/Repurchased | 69.15M | 68.71M | 122.84M | 74.25M | 280.00K | |||
| Other Financing Activity | -251.00K | -631.00K | -4.81M | 0.00 | -280.00K | |||
| FINANCING CASH FLOW | 90.64M | 88.52M | 117.23M | 74.25M | 12.39M | |||
| Exchange Rate Effect | -10.00K | 99.00K | -110.00K | -320.00K | 400.00K | |||
| CHANGE IN CASH | -33.17M | -22.78M | 39.92M | 2.40M | -47.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -103.60M | -96.51M | -77.10M | -70.91M | -58.82M | |||
| Capital Expenditure | -109.00K | -60.00K | -100.00K | -620.00K | -1.36M | |||
| FREE CASH FLOW | -103.71M | -96.57M | -77.20M | -71.53M | -60.18M | |||
All data in USD